GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy
Krzysztof Kiryluk(Columbia University)
Cited by 5
Related Papers
Medical records-based chronic kidney disease phenotype for clinical care and “big data” observational and genetic studies
|npj Digital Medicine|2021|73
Polygenic risk alters the penetrance of monogenic kidney disease
|Nature Communications|2023|59
Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits
|Nature Communications|2022|53
GWAS highlights the neuronal contribution to multiple sclerosis susceptibility
|Research Square|2025|2